UNIVERCELLS TECHNOLOGIES
25
Description
Univercells Technologies delivers novel biomanufacturing platforms as a direct answer to the growing demand for viral vaccines and viral vectors. We leverage integration and continuous processing principles to significantly reduce the overall manufacturing footprint and deliver cost-effective and scalable manufacturing of high-quality therapies.
A unique fixed-bed technology for intensified processes
The scale-X™ bioreactor delivers intensified production of adherent and suspension cells as well as viral products. Its unique proprietary structured fixed-bed design consist of spiral-wound alternating sheets of non-woven PET fabric and spacer netting.
Scalability in the scale-X bioreactor range relies on the principle of constant linear velocity of fluids with surface area increase. This ensures that the residence time remains constant at any scale.